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PICTORIAL ESSAY

Radiologic Manifestations of Pulmonary Vein Ablation
Complications: A Pictorial Review
Hannan Saad, MD, Daniel T. Myers, MD, Thomas K. Song, MD,
and Jeffrey Nadig, MD

Abstract: In patients with atrial ﬁbrillation refractory to drug therapy
and cardioversion, pulmonary vein ablation is an alternative treatment
that eradicates arrhythmogenic activity originating in the muscles of the
pulmonary veins. While this procedure has a low incidence of signiﬁcant
complications, iatrogenic injuries are possible. Through multimodality
pictorial examples utilizing computed tomography, nuclear medicine,
ﬂuoroscopy, and chest radiographs, the complications associated with
pulmonary vein ablation will be reviewed. Examples of pulmonary vein
stenosis, right phrenic nerve injury with associated diaphragmatic
paralysis, atrioesophageal ﬁstula, and pericardioesophageal ﬁstula will
be illustrated.
Key Words: pulmonary vein ablation, atrioesophageal ﬁstula,
phrenic nerve injury, pericardioesophageal ﬁstula, pulmonary vein
stenosis

(J Thorac Imaging 2020;00:000–000)

trial ﬁbrillation is the most common cardiac arrhythmia
and a signiﬁcant source of morbidity and mortality in the
United States. Deﬁned as uncoordinated atrial activation that
results in impaired mechanical atrial function, it ultimately
originates from ectopic myocardial beats that either possess
enhanced automaticity or an aberrant reentry circuit.1 While it
was ﬁrst believed that the ectopic beats originated from within
the atrial myocardium, research in 1998 demonstrated that the
myocardial sleeves encasing the pulmonary veins were in fact
an important source of ectopic beats, particularly in paroxysmal atrial ﬁbrillation.2 The sequelae of atrial ﬁbrillation at a
cellular level are severe; the longer atrial ﬁbrillation goes
untreated, the more likely atrial remodeling is to occur, which
leads to scarring, irreversible atrial enlargement, impaired
cardiac function, and an increased likelihood of stroke.1
The main clinical strategy for managing patients with
atrial ﬁbrillation is that of cardioversion by way of rate or
rhythm control—namely utilizing medications to decrease
the ventricular response rate and thereby preventing
tachycardia-related cardiomyopathy. In patients with sustained paroxysmal atrial ﬁbrillation refractory to pharmacologic treatment or electrical cardioversion, catheter ablation is
considered an effective second-line therapy. The pulmonary
vein ablation procedure speciﬁcally targets and eradicates the
arrhythmogenic activity within the muscle sleeves of the
pulmonary veins through application of either cryothermal
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energy or radiofrequency energy.3 Radiofrequency energy
yields myocardial ablation by conducting an alternating
electrical current through myocardial tissue, thereby increasing
tissue resistivity and generating heat, which conducts passively
to deeper tissue layers. Tissues exposed to temperatures of > 50°
C undergo irreversible coagulation necrosis. Cryoablation is a
process that yields tissue injury by facilitating ice crystal
formation within a cell, which disrupts the cell membrane, and
thereby disrupts cellular metabolism and electrical activity. This
is achieved by delivering liquid nitrous oxide under pressure
through a catheter to its tip, where it changes to gas and cools
the surrounding tissue.4
During both procedures electrode catheters are positioned at the site of the His bundle and distal coronary sinus
to detect aberrant electrical activity. Subsequently, following transseptal puncture, mapping and ablation catheters
are placed into pulmonary veins. Following anatomic
mapping of the pulmonary veins, either radiofrequency
energy or cryotherapy is applied 1 to 2 cm around each
ostium of the right and left pulmonary veins. During radiofrequency ablation, a maximal power output of 70 W is
applied for 20 to 40 seconds until the amplitude of aberrant
activity displayed on the electrogram drops by 80%.5
Notably, sometimes radiofrequency energy is also applied to
the posterior wall of the left atrium. In cryoablation, freezing cycles at a temperature of −80°C are used for ablation,
with conﬁrmation of electrical isolation upon electrogram
demonstration of sudden loss of electrical activity within the
pulmonary veins compared with the left atrium.6
Catheter ablation is relatively effective, particularly in
patients with paroxysmal atrial ﬁbrillation, as opposed
to persistent/longstanding atrial ﬁbrillation. A worldwide
survey reviewing outcomes of ablation cases performed
between 2003 and 2006 demonstrated an 80% success rate
after an average of 1.3 ablation procedures per patient.4
Although widely regarded as a safe procedure, it can be
associated with signiﬁcant complications. The simple
application of radiofrequency or cryotherapy could result in
an excessive inﬂammatory response that may lead to
extensive local scarring, and, ultimately, pulmonary vein
stenosis. Furthermore, the close proximity of the esophagus,
pericardium, right phrenic nerve, and left atrium to the
pulmonary veins render them susceptible to direct injury
(Fig. 1). Multiple studies have reported a 2% to 5% periprocedural complication rate, the majority of which are
vascular in nature. The relatively more common injuries
observed after pulmonary vein ablation include pulmonary
vein stenosis, right phrenic nerve injury, and complications
related to the site of vascular access. Rarer complications
include esophageal injuries including both atrioesophageal
ﬁstula and pericardioesophageal ﬁstula. Additional rare
complications include tamponade, thromboembolic events,
and lung or bronchial injury.
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FIGURE 1. Axial contrast-enhanced CT images from preablation CT scans displays proximity of structures to the pulmonary vein (PV)
ostia. The esophagus (curved arrow, A) commonly courses along the posterior aspect of the left superior PV, left atrial (LA) posterior wall,
and left inferior PV. The right phrenic nerve (dashed arrow, B) is in close proximity to the anterior aspect of the right superior PV ostium.
Pericardial reflections (solid arrows, A and B) insert into close proximity to the left and right PVs.

PULMONARY VEIN STENOSIS
Radiofrequency ablation is a main cause of pulmonary
vein stenosis, and it is postulated to result from a vascular
and inﬂammatory response to radiofrequency energy that
induces scarring and collagen deposition.7 The published
incidence of pulmonary vein stenosis following catheter
ablation ranges from 0% to 38%, with an expert consensus
review from the Heart Rhythm Society in 2007 reporting an
overall incidence of <10%. While there have been case
reports of pulmonary vein stenosis following cryoablation, it
is much more rare. The symptoms of pulmonary vein
stenosis can manifest as early as 1 to 2 days after the
ablation.8 Symptoms include dyspnea, chest pain, hemoptysis, cough, recurrent lung infections, and symptoms of
pulmonary hypertension.4 Some studies suggest a direct
correlation with increased radiofrequency energy and the
degree of pulmonary vein stenosis, namely patients who
have undergone procedures with > 30 W of ablation energy
have a higher propensity to develop severe stenosis.9 While
the majority of the cases of pulmonary vein stenosis are mild
stenosis without clinical consequence, a minority of these
cases results in severe stenosis. A severe stenosis is deﬁned as
a > 70% diameter reduction of a pulmonary vein. Severe
stenosis can lead to pulmonary infarction, pulmonary

venoocclusive disease, or pulmonary arterial hypertension,
which may require intervention consisting of balloon dilatation and stenting.10 On transesophageal echocardiography, pulmonary vein stenosis is identiﬁed as an increased
peak systolic velocity within the pulmonary veins or a narrowed diameter of the veins. A contrast-enhanced computed
tomography (CT) of the chest demonstrates a narrowed
caliber of the involved pulmonary vein (Fig. 2). Should
pulmonary venous hypertension or pulmonary venous
infarct occur, CT thorax may demonstrate interlobular
septal thickening and ground-glass opacities in the distribution of the stenotic vessel. Chest radiograph or CT
thorax may show heterogeneous or patchy airspace opacity
corresponding to the infarcted parenchyma.11 A nuclear
medicine ventilation perfusion study may allow for conﬁrmation of pulmonary vein stenosis by demonstrating differential perfusion within the lungs (Fig. 3).

RIGHT PHRENIC NERVE INJURY
Direct thermal injury to the right phrenic nerve can be seen
in either radiofrequency or cryoablation, although it is most
commonly seen following cryoballoon ablation of the right-sided
pulmonary veins. While phrenic nerve injury can be seen in up to

FIGURE 2. A 48 year-old man status postpulmonary vein ablation. Axial contrast-enhanced CT (A) demonstrates near-complete
occlusion of right superior pulmonary vein (arrow) confirmed by catheterization. Reconstructed vessel probe image demonstrates the
severe stenosis (B, arrow). There is prestenotic dilatation of the right superior pulmonary vein (C, arrow).
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FIGURE 3. Posterior ventilation (A) and perfusion (B) images from a nuclear medicine ventilation perfusion scan of a dyspneic 39-year-old
man with atrial fibrillation status postradiofrequency ablation demonstrate markedly decreased perfusion of the left lung compared with
the right (red box), quantified as 15% left and 85% right. Axial contrast-enhanced CT of the chest (C) shows severe stenosis of the left
inferior pulmonary vein (white arrow). Angioplasty was unsuccessful, and stenosis was treated with stent placement. Image courtesy of Dr
E. Kazerooni.

10.8% of patients following cryoballoon ablation, the reported
incidence of phrenic nerve injury following radiofrequency energy
is <1%.4 It has been postulated that the inﬂated balloon devices
themselves not only create a broader thermal gradient, but also
distort the anatomic distance between the right superior pulmonary vein endocardium and the right phrenic nerve. Furthermore,
smaller balloon devices, such as those used during cryoablation,
carry a higher risk for phrenic nerve injury, as they are placed
more distally within the pulmonary veins.4 The right phrenic
nerve is susceptible to injury, as it runs posterior to the subclavian
vein and crosses anteriorly over the root of the right lung at the
origin of the pulmonary veins. Notably, left phrenic nerve injury
does not occur, as the course of the left phrenic nerve is anterior
and within the pericardium. Phrenic nerve injury can be
asymptomatic, or manifest as dyspnea, hiccups, atelectasis,
cough, and thoracic pain.12 On conventional radiograph, a newly
elevated right hemidiaphragm after the ablation should raise
suspicion for right phrenic nerve injury. A conﬁrmatory ﬂuoroscopic sniff test would demonstrate paradoxical upward motion
of the right hemidiaphragm with increased intrathoracic pressure
(snifﬁng), as negative intrathoracic pressure causes a nonfunctioning diaphragm to move upward (Fig. 4).

ESOPHAGEAL INJURIES
The close proximity of the esophagus to the posterior wall
of the left atrium makes it highly susceptible to injury, thermal or
mechanical, during the catheter ablation procedure. The complications of esophageal damage can be severe, and thus the
procedure necessitates usage of several safeguards to prevent
injury. The most common of these safeguards is known as
modifying energy delivery, essentially lowering power delivery on
the posterior wall of the left atrium to < 25 W during radiofrequency ablation. Despite this precaution, injury to the esophagus may still occur if ablation duration is prolonged or contact
force signiﬁcant. As such, an additionally used strategy requires
movement of the ablation catheter every 10 to 20 seconds along
the atrial wall. A second safeguard against esophageal injury is
that of esophageal visualization; by utilizing multidetector CT
or topographic tagging with an electroanatomical mapping
system, operators can either avoid the esophagus altogether or
use lower power and/or alternative energy to ablate lesions over
the esophagus. A third safeguard involves use of luminal
esophageal temperature monitoring to identify dangerous heating
of the esophagus. While there is no consensus with regard to the
exact esophageal temperature at which ablation can be

FIGURE 4. Baseline chest radiograph (A) of a 62-year-old woman with a history of paroxysmal atrial fibrillation demonstrating relative
symmetric position of the hemidiaphragms. Two weeks after radiofrequency ablation, the patient presented with new-onset dyspnea.
Inspiratory (B) and expiratory (C) chest radiographs demonstrate new right hemidiaphragm elevation (white arrows). A fluoroscopic sniff
test confirmed paradoxical motion of the right hemidiaphragm, diagnostic of right phrenic nerve injury and diaphragmatic paralysis.
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FIGURE 5. A 70-year-old woman presented with stroke-like symptoms ~3 weeks after catheter ablation for atrial fibrillation. Contrastenhanced axial (A) and sagittal (B) images from CT of the thorax demonstrate loss of fat plane between the esophagus and left atrium with a
few pockets of air in the dependent atrium abutting the esophagus (black arrows), strongly suggestive of an atrioesophageal fistula.

terminated, some studies have recommended cessation of radiofrequency ablation with a 2°C rise in luminal esophageal
temperature.4 Esophageal ulcerations, perforations, and atrioesophageal ﬁstulas have all been reported after ablation. Postablation esophageal ulcers immediately posterior to the left
atrium have a reported incidence of up to 60% in one study,4 all
of which were conﬁrmed with endoscopy. Notably, these were
usually healed on follow-up endoscopy 2 to 3 weeks later.
Atrioesophageal ﬁstula is the most severe of esophageal
injuries, and has a high mortality rate, which approaches
100%. The overall incidence of atrioesophageal ﬁstula is
<1%.13 Clinical manifestations of an atrioesophageal ﬁstula
typically present within 2 to 4 weeks after the ablation
procedure.
Patients most often have a clinical presentation of stroke
and sepsis, as ingested material enters the left atrium via the
ﬁstula and is embolized to the brain and other organs. Radiologists must be vigilant as a CT head may be the ﬁrst ordered
study in such a patient, potentially demonstrating multiple
embolic infarcts within the brain, some of which may contain air
emboli. The presence of air emboli should trigger a review of the
recent past medical history for pulmonary vein ablation, as that
history frequently may not be provided in the setting of a

neurological presentation. A CT of the thorax can demonstrate a
near-pathognomonic ﬁnding of small bubbles of air within the
dependent left atrium adjacent to the esophagus (Fig. 5). Less
commonly, an air-ﬁlled communication between the atrium and
esophagus will be seen (Fig. 6).
Serous pericardium, the innermost layer of pericardium,
is reﬂected onto the heart as epicardium and has attachments
to the pulmonary veins, SVC, aorta, and pulmonary trunk. As
such, direct injury to the pericardium and esophagus during
the ablation procedure could result in a ﬁstulous tract between
the 2. Termed pericardioesophageal ﬁstula, this is a rare
complication with the ﬁrst reported case in 2010.14 This condition usually manifests 2 to 4 weeks after surgery with nonspeciﬁc complaints, including epigastric and substernal chest
pain. Chest radiograph in these patients may demonstrate an
air-ﬂuid level within the pericardium, with diagnostic conﬁrmation established after demonstration of passage of contrast material from the esophagus into the pericardium on
ﬂuoroscopy.15 Findings of pericarditis or pericardial effusion
may be other indications of a pericardioesophageal ﬁstula. The
presence of pneumopericardium on CT in the setting of prior
pulmonary vein ablation is strongly suggestive of pericardioesophageal ﬁstula (Fig. 7).

FIGURE 6. A 42-year-old man with atrial fibrillation status-post left atrial radiofrequency ablation presented with bilateral upper extremity
weakness and dysphagia 2 weeks after the procedure. Contrast-enhanced axial (A) and sagittal (B) images from a CT thorax demonstrate
linear collection of air extending from the esophagus to the left atrium (black arrows), consistent with an atrioesophageal fistula.
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FIGURE 7. A 50-year-old man who became hypotensive during his ablation procedure and bedside echocardiogram demonstrated
cardiac tamponade. Axial image from noncontrast CT chest on soft tissue (A) and lung window (B) after his procedure shows hydropneumopericardium (arrows). A pericardioesophageal fistula was subsequently confirmed.

FIGURE 8. Images from 3 different patients demonstrating local vascular complications related to femoral arterial access. Axial image
from contrast-enhanced CT angiogram of the pelvis (A) demonstrates a focal hematoma superficial to the left femoral vessels (white
arrow). Sagittal image from contrast-enhanced CT angiogram of the pelvis (B) demonstrates a focal pseudoaneurysm arising off of the
anterior aspect of the left superficial femoral artery (white arrow). Axial image from a contrast-enhanced CT of the pelvis (C) displays a
heterogeneous high-attenuation left pelvic hematoma (white arrow).

Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.
www.thoracicimaging.com
Copyright r 2020 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
This paper can be cited using the date of access and the unique DOI number which can be found in the footnotes.

|5

J Thorac Imaging

Saad et al



Volume 00, Number 00, ’’ 2020

FIGURE 9. Axial noncontrast CT scan of the brain in 2 different patients demonstrating embolic complications of pulmonary vein
ablation. In a patient with atrioesophageal fistula after ablation (A) a cluster of gas bubbles (white arrow) is present from air emboli. A
different patient (B) recently status postablation demonstrates multiple rounded infarcts in the left cerebral hemisphere (white arrows), as
well as larger infarct in the right cerebral hemisphere from embolic phenomena.

ADDITIONAL COMPLICATIONS
Cardiac Perforation and Tamponade
The incidence of myocardial perforation and tamponade following pulmonary vein ablation has been estimated
to be 0.5% to 4%, although a study in 2005 by the Mayo
Clinic Study reports an incidence as high as 2.1%.16 The
most common causes of cardiac perforation and subsequent
tamponade during catheter ablation result from misdirected
transseptal punctures (exit through the right or left atria),
direct mechanical trauma, and overheating during radiofrequency energy delivery.4 Cardiac tamponade manifests as
either an abrupt drop or gradual decrease in blood pressure.
Notably, an intracardiac echocardiogram will demonstrate
an effusion before the onset of hemodynamic instability.
Tamponade can also occur 1 hour or more following the
ablation procedure. Cardiac tamponade is managed immediately by subxiphoid percutaneous drainage and reversal of
anticoagulation. The actual perforated myocardium, however, rarely requires surgical intervention. Of note, it is
estimated that 66.7% of patients with myocardial perforation develop early recurrence of atrial ﬁbrillation.17
Notably, in the same Mayo Clinic study, 10 of 15 patients
who had their ablation procedure complicated by myocardial perforation developed early recurrent atrial ﬁbrillation, despite having their procedures completed. This is
likely secondary to the myocardial and pericardial inﬂammatory
reaction associated with perforation, which results in cellular
dysfunction and thus enhanced arrhythmogenicity.16,17
Vascular complications, primarily involving the femoral access site, are common, with a published incidence
ranging from 0% to 13%. Groin hematomas are the most
frequently encountered complication, although cases of
arterial pseudoaneurysms, femoral arteriovenous ﬁstulas,
and retroperitoneal hemorrhage have been reported (Fig. 8).
Intuitively, these complications are linked to the number
and size of the catheters used, as well as the patients’ anticoagulation status. Vascular injuries in the vicinity of the
ablation site have also been reported to occur. Such possible
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complications include hemothorax, subclavian hematoma,
and extrapericardial pulmonary vein perforation.
The incidence of thromboembolic events after ablation,
be they from air emboli or thromboemboli, have a reported
occurrence of 0% to 7%.4 These events typically occur
within 24 hours of the ablation procedure with the high-risk
period extending for up to 2 weeks after the procedure.
Thrombi can occur either from stationary sheaths or originate from a left atrial appendage thrombus, and are the
reason for the current aggressive preprocedural and intraprocedural prophylactic anticoagulation protocols. Air
emboli usually are introduced by way of sheath or catheter
placement but may be secondary to atrioesophageal ﬁstula
(Fig. 9). While intracranial emboli are most commonly
reported, coronary arterial or abdominal vascular emboli
are also possible. Patients presenting with altered mental
status, new-onset seizures, or a focal neurological deﬁcit
should undergo emergent brain CT or magnetic resonance
imaging. Notably, air emboli preferentially migrate into the
right coronary artery. As such, a patient presenting with
acute-onset chest pain after their ablation procedure with
ECG ﬁndings of acute inferior ischemia or heart block
should be presumed to have a right coronary artery infarction secondary to an air embolism until proven otherwise.4
Hemoptysis is an uncommon complication of pulmonary ablation with an incidence of 0% to 2.1%.4 While
hemoptysis can be a symptom of pulmonary vein stenosis, it
is not always the case. Hemoptysis can simply be a manifestation of transient interruption of vascular integrity
within the pulmonary capillary system, which is associated
with lower freezing temperatures. Rarely, hemoptysis can be
seen with bronchial erosion given the close proximity of the
pulmonary veins to the bronchial tree. The ﬁrst case of
bronchial erosion was reported in 2011.18 Naturally, bronchoscopy may be warranted in a patient with hemoptysis. A CT of
the thorax may or may not demonstrate the bronchial erosion or
ﬁstulous connection between the bronchus or pulmonary vein;
however, it could demonstrate ground-glass opacity/edema
adjacent to the vein, suspicious for injury.
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CONCLUSION

Although the imaging ﬁndings may be nuanced, many
of the complications of pulmonary vein ablation for atrial
ﬁbrillation have ﬁndings on radiology examinations that are
near pathognomonic. As such, it is paramount that radiologists familiarize themselves with the pulmonary vein
ablation procedure and potential complications to allow for
early recognition, diagnosis, and potential treatment.
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